Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

Brigham and Women's Hospital, Abbott (United Kingdom), Bristol-Myers Squibb (Germany), University of Colorado Denver, Leiden University Medical Center, Sanofi (France), Pfizer (United States), Instituto Nacional de Rehabilitación Psicofísica, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (France), The University of Texas Southwestern Medical Center